Bernardini, Roberta
Tengattini, Sara
Li, Zhihao
Piubelli, Luciano
Bavaro, Teodora
Modolea, Anamaria Bianca
Mattei, Maurizio
Conti, Paola
Marini, Stefano
Zhang, Yongmin
Pollegioni, Loredano
Temporini, Caterina
Terreni, Marco
Funding for this research was provided by:
Italian Ministry of Health (T4-CN-02, T4-CN-02, T4-CN-02, T4-CN-02, T4-CN-02, T4-CN-02, T4-CN-02, T4-CN-02)
Article History
Received: 7 November 2023
Accepted: 18 January 2024
First Online: 25 January 2024
Declarations
:
: The Ethics Committee of the University of Rome “Tor Vergata” (Rome, Italy) approved the study protocol (protocol number 173/19) “Valutazione biologica Ex Vivo di nuovi glicoconiugati semi-sintetici derivati da proteine antigenetiche ricombinanti di Mycobacterium tuberculosis - Ex Vivo biological evaluation of new semi-synthetic glycoconjugates derived from recombinant antigenic proteins of <i>Mycobacterium tuberculosis</i>”.
: Not applicable.
: The authors declare no competing interests.